IC50 (functional)
|
= 8.9 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum NF54 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 10.2 nM
|
Antiparasitic activity against chloroquine sensitive Plasmodium falciparum 3D7
|
ChEMBL.
|
18260613
|
IC50 (functional)
|
= 10.2 nM
|
Antiparasitic activity against chloroquine sensitive Plasmodium falciparum 3D7
|
ChEMBL.
|
18260613
|
IC50 (functional)
|
= 22.6 nM
|
Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 29 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 8425 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 35.2 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 3D7 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 35.6 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 63.2 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum L1 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 63.7 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Voll infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 64 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum PA infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (ADMET)
|
= 64 nM
|
Cytotoxicity against human MRC5 after 3 days
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 86.1 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCR3 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 96.7 nM
|
Antiparasitic activity against chloroquine resistant Plasmodium falciparum K1
|
ChEMBL.
|
18260613
|
IC50 (functional)
|
= 96.7 nM
|
Antiparasitic activity against chloroquine resistant Plasmodium falciparum K1
|
ChEMBL.
|
18260613
|
IC50 (functional)
|
= 129.1 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Bres infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 129.7 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 168.7 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum W2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 171 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K14 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 238.8 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCM29 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC50 (functional)
|
= 30.4 uM
|
Antiproliferative activity against human carmustine-resistant NCH-89 cells assessed as BrdU incorporation after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 59.4 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 8425 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 65.6 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 3D7 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 67.8 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 107.2 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum PA infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 132.4 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum L1 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 134.6 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Voll infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 164.4 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCR3 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 217.8 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Bres infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 285.1 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 316.2 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K14 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 319.9 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum W2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
IC90 (functional)
|
= 369 nM
|
Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCM29 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs
|
ChEMBL.
|
20329733
|
MIC (functional)
|
> 100 ug ml-1
|
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate alamar blue assay
|
ChEMBL.
|
19188070
|
Ratio IC50 (functional)
|
= 9.5
|
Ratio of IC50 for Plasmodium falciparum K1 to IC50 for Plasmodium falciparum 3D7
|
ChEMBL.
|
18260613
|
Ratio IC50 (functional)
|
= 9.5
|
Ratio of IC50 for Plasmodium falciparum K1 to IC50 for Plasmodium falciparum 3D7
|
ChEMBL.
|
18260613
|
TD50 (functional)
|
= 89.8 uM
|
Cytotoxicity against human KB cells by alamar blue assay
|
ChEMBL.
|
18260613
|
TD50 (functional)
|
= 89.8 uM
|
Cytotoxicity against human KB cells by alamar blue assay
|
ChEMBL.
|
18260613
|